ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 229

$784K Total Retail Price of All Prescriptions

Rank: 16 out of 229

481 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 9,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 702 598 1 1
SIMVASTATIN 376 322 2 3
OMEPRAZOLE 332 280 3 4
LISINOPRIL 289 263 4 2
METFORMIN HCL 258 235 5 6
CIPROFLOXACIN HCL 239 214 6 58
POTASSIUM CHLORIDE 179 154 7 18
TRIAMTERENE-HCTZ 159 140 8 51
HYDROCODONE-ACETAMINOPHEN 157 113 S3 9 7
METOPROLOL SUCCINATE 152 141 10 16
AMLODIPINE BESYLATE 148 140 11 5
IBUPROFEN 125 100 12 60
ATORVASTATIN CALCIUM 122 114 13 15
CLOPIDOGREL 115 111 14 44
TAMSULOSIN HCL 114 111 15 24
ZOLPIDEM TARTRATE 110 103 16 20
FUROSEMIDE 108 91 17 8
WARFARIN SODIUM 105 103 18 17
ADVAIR DISKUS 103 80 19 47
TRAMADOL HCL 103 99 19 26
SPIRONOLACTONE 102 101 21 56
ATENOLOL 98 88 22 19
DIGOXIN 93 82 23 92
NAPROXEN 91 75 24 94
NEXIUM 87 68 25 48
MELOXICAM 84 77 26 45
CEPHALEXIN 83 72 27 87
SYNTHROID 82 69 28 46
ENALAPRIL MALEATE 82 82 28 54
GABAPENTIN 77 77 30 10
PRAVASTATIN SODIUM 75 75 31 25
PLAVIX 75 74 31 72
PREDNISONE 74 53 33 35
CRESTOR 73 50 34 30
GUANFACINE HCL 72 61 R 35 256
NIFEDIPINE ER 71 71 36 206
CITALOPRAM HBR 70 59 37 21
ALENDRONATE SODIUM 70 48 37 14
PROAIR HFA 68 41 39 38
DONEPEZIL HCL 67 67 40 29
ZETIA 66 45 41 93
METOPROLOL TARTRATE 66 57 41 13
GLYBURIDE 64 64 R 43 57
FENOFIBRATE 63 47 44 68
SINGULAIR 61 48 45 119
ETODOLAC 59 47 46 214
CLONIDINE HCL 59 55 46 69
NAMENDA 56 56 48 39
DIOVAN 55 55 49 42
LOVASTATIN 55 43 49 11
CARISOPRODOL 55 28 R 49 104
SPIRIVA 54 23 52 76
SYMBICORT 53 47 53 118
HYDROCHLOROTHIAZIDE 53 51 53 9
LANTUS SOLOSTAR 53 29 53 85
CARVEDILOL 52 40 56 31
AMOXICILLIN 52 39 56 142
LOSARTAN POTASSIUM 52 43 56 12
MIRTAZAPINE 52 52 56 52
INSULIN SYRINGE 52 49 56 83
FLUDROCORTISONE ACETATE 52 41 56 293
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.